Lipocine Inc.

News & Events

Press Releases

In The Media

1. Lipocine's LPCN 1148 Highlighted in the June 2025 Edition of Hepatology

   PR Newswire MAY 22, 2025 8:00 AM EDT
   Lipocine's LPCN 1148 Highlighted in the June 2025 Edition of Hepatology PR Newswire ...
   READ ARTICLE

2. Lipocine to Present at A.G.P.'s Annual Healthcare Company Showcase

   PR Newswire MAY 14, 2025 8:00 AM EDT
   Lipocine to Present at A.G.P.'s Annual Healthcare Company Showcase PR Newswire ...
   READ ARTICLE

3. Lipocine Announces Financial Results for the First Quarter Ended March 31, 2025

   PR Newswire MAY 8, 2025 8:00 AM EDT
   Lipocine Announces Financial Results for the First Quarter Ended March 31, 2025 PR News...
   READ ARTICLE

4. Lipocine Announces License and Supply Agreement for TLANDO® in Brazil

   PR Newswire MAY 6, 2025 8:00 AM EDT
   Lipocine Announces License and Supply Agreement for TLANDO® in Brazil PR Newswire ...
   READ ARTICLE

5. Lipocine Announces Initiation of Outpatient Phase 3 Postpartum Depression Trial of LPCN 1154

   PR Newswire MAR 26, 2025 8:00 AM EDT
   Lipocine Announces Initiation of Outpatient Phase 3 Postpartum Depression Trial of LPCN 1154 ...
   READ ARTICLE

6. Lipocine Announces Financial Results for the Full Year Ended December 31, 2024

   PR Newswire MAR 13, 2025 8:00 AM EDT
   Lipocine Announces Financial Results for the Full Year Ended December 31, 2024 PR Newsw...
   READ ARTICLE

7. Lipocine Announces FDA Labeling Changes for Testosterone Products

   PR Newswire MAR 12, 2025 8:00 AM EDT
   Lipocine Announces FDA Labeling Changes for Testosterone Products PR Newswire ...
   READ ARTICLE

8. Lipocine Receives Updated Regulatory Guidance on LPCN 1154

   PR Newswire FEB 6, 2025 8:00 AM EST
   Lipocine Receives Updated Regulatory Guidance on LPCN 1154 PR Newswire SALT...
   READ ARTICLE

9. FDA Grants Fast Track Designation to Lipocine for LPCN 1148 as a Treatment for Sarcopenia in Patients with Decompensated Cirrhosis

   PR Newswire DEC 17, 2024 8:00 AM EST
   FDA Grants Fast Track Designation to Lipocine for LPCN 1148 as a Treatment for Sarcopenia in Pati...
   READ ARTICLE

10. Lipocine And Antares Pharma Enter Into U.S. Licensing Agreement To Commercialize TLANDO®

    Canada Newswire OCT 18, 2021 7:00 AM EDT
    Lipocine And Antares Pharma Enter Into U.S. Licensing Agreement To Commercialize TLANDO&#...
    READ ARTICLE